The Robert A. Winn Diversity in Clinical Trials Award Program Bristol Myers Squibb: Design and Implementation of Clinical Trials Workshop
Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (BMSF DCTCDP) in collaboration with the American Association for Cancer Research (AACR) and the National Medical Fellowships (NMF)
November 14-19, 2022
The Loews Santa Monica
Santa Monica, California
Roy S. Herbst, Yale University Cancer Center, New Haven, Connecticut
Yu Shyr, Vanderbilt University Medical Center, Nashville, Tennessee
Robert A. Winn, VCU Massey Cancer Center, Richmond, Virginia
Elliott Antman, Brigham and Women’s Hospital, Boston, Massachusetts
Peter A. Calabresi, Johns Hopkins University School of Medicine, Baltimore, Maryland
Nancy E. Davidson, Fred Hutchinson Cancer Research Center, Seattle, Washington
Carmen E. Guerra, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
Ruben A. Mesa, Mays Cancer Center, San Antonio, Texas
Marcia R. Cruz-Correa, University of Puerto Rico School of Medicine, San Juan, Puerto Rico
This multidisciplinary, intensive Educational Workshop will introduce early-stage investigators (as defined by NIH) underrepresented in medicine, or physicians who have a demonstrated commitment to increasing diversity in clinical research, to the principles of effective clinical trial design and community engagement. Physicians with a focus in cancer (hematology and oncology), cardiovascular disease, non-benign hematologic diseases, and immunologic disorders, selected to participate in the Workshop will be provided with the educational foundation and the tools needed to conduct clinical trials that will have the potential to increase the participation of diverse populations in clinical trials and ultimately impact patient care.
The Workshop will expose early-stage investigators to the full spectrum of challenges in clinical research – i.e., surgery; radiotherapy; immunotherapy; targeted therapy; treatment with conventional and investigational agents and devices; multidisciplinary treatment regimens; multimodality and combination treatments; the integration of biomarkers in clinical trials; and the application of data science, machine learning, and emerging technologies to clinical research and digital health.
Participants will be encouraged to devote all or a portion of their future careers to some aspect of clinical research in underrepresented populations. Developing a workforce of diverse, well-trained, clinical researchers will foster better clinical trial design by advancing the introduction of improved approaches to therapy and intervention into everyday medical practice and patient care in underrepresented populations.
The Workshop will address the frequent disconnect between communities and clinical trialists by teaching effective methods that create structures for communities to help refine clinical questions and trials for improved patient benefit. Bridging the gap between clinical researchers and the communities they serve by utilizing highly innovative approaches to clinical research will be a unique and key component of the educational program that is not addressed in other clinical trial educational programs.
A multi-year, structured, mentoring program will be tailored to each participant’s clinical focus to help establish a network of those underrepresented in medicine who have a demonstrated commitment to increasing diversity in clinical research. A primary goal of this program is to not only develop a more diverse and active population of experts within the clinical trial infrastructure, but also to help participants achieve leadership positions at their institutions and within professional scientific/clinical societies, publish their work in scholarly journals to advance medical science and patient care, develop skills to serve as mentors for future generations of aspiring clinical trialists from underrepresented populations, and participate as Faculty members in future programs.